Form 8-K - Current report:
SEC Accession No. 0001628280-24-035229
Filing Date
2024-08-06
Accepted
2024-08-06 16:26:59
Documents
31
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abcl-20240806.htm   iXBRL 8-K 27578
2 EX-99.1 q22024earningspressrelease.htm EX-99.1 175119
3 EX-99.2 q2248kearningsdeckfinal.htm EX-99.2 12774
7 capture.jpg GRAPHIC 48406
8 q2248kearningsdeckfinal001.jpg GRAPHIC 43288
9 q2248kearningsdeckfinal002.jpg GRAPHIC 144001
10 q2248kearningsdeckfinal003.jpg GRAPHIC 64365
11 q2248kearningsdeckfinal004.jpg GRAPHIC 70191
12 q2248kearningsdeckfinal005.jpg GRAPHIC 88260
13 q2248kearningsdeckfinal006.jpg GRAPHIC 84027
14 q2248kearningsdeckfinal007.jpg GRAPHIC 77883
15 q2248kearningsdeckfinal008.jpg GRAPHIC 69075
16 q2248kearningsdeckfinal009.jpg GRAPHIC 57169
17 q2248kearningsdeckfinal010.jpg GRAPHIC 85008
18 q2248kearningsdeckfinal011.jpg GRAPHIC 72915
19 q2248kearningsdeckfinal012.jpg GRAPHIC 70609
20 q2248kearningsdeckfinal013.jpg GRAPHIC 47398
21 q2248kearningsdeckfinal014.jpg GRAPHIC 61678
22 q2248kearningsdeckfinal015.jpg GRAPHIC 68638
  Complete submission text file 0001628280-24-035229.txt   1938754

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20240806.xsd EX-101.SCH 1907
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20240806_lab.xml EX-101.LAB 20678
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20240806_pre.xml EX-101.PRE 11962
34 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20240806_htm.xml XML 2593
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 241179753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)